Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis

Dementia and Geriatric Cognitive Disorders

Volumn 41, Issue 1-2, 2016, Pages 109-122

  Kansal, Kalyani ^a   Mareddy, Manisha ^e   Sloane, Kelly L ^a,b   Minc, Alexa A ^c   Rabins, Peter V ^a   McGready, John B ^d   Onyike, Chiadi U ^a,f  

^a Division of Geriatric Psychiatry and Neuropsychiatry   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JSS MEDICAL COLLEGE   (India)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Corticobasal degeneration; Epidemiology; Frontotemporal dementia; Life expectancy; Progressive non fluent aphasia; Progressive supranuclear palsy; Semantic dementia; Survival; Years of life lost

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CORTICOBASAL DEGENERATION; EDUCATION; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; HUMAN; LANGUAGE; MEDICAL HISTORY; META ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SEMANTIC DEMENTIA; SURVIVAL; AGED; FEMALE; MALE; MORTALITY; SURVIVAL RATE;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; PHENOTYPE; PRIMARY PROGRESSIVE NONFLUENT APHASIA; SUPRANUCLEAR PALSY, PROGRESSIVE; SURVIVAL RATE;

EID: 84957899962     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000443205     Document Type: Review

References (70)

1. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006-1014.
2. Onyike CU: What is the life expectancy in frontotemporal lobar degeneration? Neuroepidemiology 2011;37:166-167.
3. Josephs KA, Knopman DS, Whitwell JL, Boeve BF, Parisi JE, Petersen RC, et al. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 2005;65:645-647.
4. Hodges JR, Davies R, Xuereb J, Kril J, Halliday G: Survival in frontotemporal dementia. Neurology 2003;61:349-354.
5. Kang SJ, Cha KR, Seo SW, Kim EA, Cheong HK, Kim EJ, et al. Survival in frontotemporal lobar degeneration in a Korean population. Alzheimer Dis Assoc Disord 2010;24:339-342.
6. Hu WT, Seelaar H, Josephs KA, Knopman DS, Boeve BF, Sorenson EJ, et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol 2009;66:1359-1364.
7. Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005;65:719-725.
8. Nunnemann S, Last D, Schuster T, Förstl H, Kurz A, Diehl-Schmid J: Survival in a German population with frontotemporal lobar degeneration. Neuroepidemiology 2011;37:160-165.
9. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology 2005;65:397-403.
10. Pasquier F, Richard F, Lebert F: Natural history of frontotemporal dementia: comparison with Alzheimer's disease. Dement Geriatr Cogn Disord 2004;17:253-257.
11. Koedam ELGE, Pijnenburg YAL, Deeg DJH, Baak MME, van der Vlies AE, Scheltens P, et al. Early-onset dementia is associated with higher mortality. Dement Geriatr Cogn Disord 2008;26:147-152.
12. Brodaty H, Seeher K, Gibson L: Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr 2012;24:1034-1045.
13. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456-2477.
14. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
15. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-418.
16. Mesulam MM: Primary progressive aphasia-differentiation from Alzheimer's disease. Ann Neurol 1987;22:533-534.
17. Mesulam MM: Primary progressive aphasia. Ann Neurol 2001;49:425-432.
18. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Semin Neurol 2014;34:129-150.
19. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC: Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034.
20. Rajput AH, Rozdilsky B, Rajput A: Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 1991;18:275-278.
21. Rajput AH, Rozdilsky B, Ang L, Rajput A: Significance of parkinsonian manifestations in essential tremor. Can J Neurol Sci 1993;20:114-117.
22. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-620.
23. Rebeiz JJ, Kolodny EH, Richardson EP: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
24. Gibb WR, Luthert PJ, Marsden CD: Corticobasal degeneration. Brain 1989;112:1171-1192.
25. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
26. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
27. Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-146.
28. Viechtbauer W: Conducting meta-analyses in R with the metafor package. J Stat Softw 2010;36:1-48.
29. Viechtbauer W: Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat 2005;30:261-293.
30. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289-300.
31. Santacruz P, Uttl B, Litvan I, Grafman J: Progressive supranuclear palsy: a survey of the disease course. Neurology 1998;50:1637-1647.
32. Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Robinson C, et al. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 2002;17:1255-1264.
33. Josephs KA, Dickson DW: Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003;18:1018-1026.
34. Kertesz A, Blair M, McMonagle P, Munoz DG: The diagnosis and course of frontotemporal dementia. Alzheimer Dis Assoc Disord 2007;21:155-163.
35. Golbe LI, Ohman-Strickland PA: A clinical rating scale for progressive supranuclear palsy. Brain 2007;130:1552-1565.
36. Ahmed Z, Josephs KA, Gonzalez J, DelleDonne A, Dickson DW: Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 2008;131:460-472.
37. Hassan A, Whitwell JL, Boeve BF, Jack CR, Parisi JE, Dickson DW, et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord 2010;16:208-214.
38. Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA: Predicting survival in frontotemporal dementia with motor neuron disease. Neurology 2011;76:1886-1893.
39. Probst A, Dufresne JJ: Paralysie supranucléaire progressive (ou dystonie oculo-facio-cervicale). Schweiz Arch Neurol Neurochir Psychiatr 1975;116:107-134.
40. Vercelletto M, Ronin M, Huvet M, Magne C, Feve JR: Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases. Eur J Neurol 1999;6:295-299.
41. Le Rhun E, Richard F, Pasquier F: Natural history of primary progressive aphasia. Neurology 2005;65:887-891.
42. Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Antérion C, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 2006;129:3051-3065.
43. Garcin B, Lillo P, Hornberger M, Piguet O, Dawson K, Nestor PJ, et al. Determinants of survival in behavioral variant frontotemporal dementia. Neurology 2009;73:1656-1661.
44. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR: Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol 2010;67:826-830.
45. Chiu WZ, Kaat LD, Seelaar H, Rosso SM, Boon AJ, Kamphorst W, et al. Survival in progressive supranuclear palsy and frontotemporal dementia. J Neurol Neurosurg Psychiatry 2010;81:441-445.
46. Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 2010;133:300-306.
47. dell'Aquila C, Zoccolella S, Cardinali V, de Mari M, Iliceto G, Tartaglione B, et al. Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients. Parkinsonism Relat Disord 2013;19:980-985.
48. Suresh TG, Rao TV: Progressive supranuclear palsy. Report of 14 cases with special reference to unusual features. J Assoc Physicians India 1991;39:471-475.
49. Aiba I, Saito Y, Tamakoshi A, Matsuoka Y: Prognosis of patients with progressive supranuclear palsy. Rinsho Shinkeigaku 2005;45:565-570.
50. Ghosh A, Dutt A, Ghosh M, Bhargava P, Rao S: Using the revised diagnostic criteria for frontotemporal dementia in India: evidence of an advanced and florid disease. PLoS One 2013;8:e60999.
51. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST: Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol 2005;62:779-784.
52. Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W: Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord 2005;19:178-183.
53. Nilsson K, Gustafson L, Hultberg B: Survival in a large elderly population of patients with dementia and other forms of psychogeriatric diseases. Dement Geriatr Cogn Disord 2011;32:342-350.
54. Wilmoth JR, Horiuchi S: Rectangularization revisited: variability of age at death within human populations. Demography 1999;36:475-495.
55. Massimo L, Zee J, Xie SX, McMillan CT, Rascovsky K, Irwin DJ, et al. Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration. Neurology 2015;84:2070-2075.
56. Goetz CG, Leurgans S, Lang AE, Litvan I: Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology 2003;60:917-922.
57. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP: The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry 2011;72:126-133.
58. Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean C: Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry 2009;194:298-305.
59. Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006;66:839-844.
60. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 2006;129:868-876.
61. Kertesz A, Munoz DG: Primary progressive aphasia and Pick complex. J Neurol Sci 2003;206:97-107.
62. Boeve BF: Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis Assoc Disord 2007;21:S31-S38.
63. Xie SX, Forman MS, Farmer J, Moore P, Wang Y, Wang X, et al. Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2008;79:126-129.
64. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006;144:73-81.
65. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007;69:1921-1930.
66. Wang HX, Karp A, Winblad B, Fratiglioni L: Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol 2002;155:1081-1087.
67. Mehta KM, Yaffe K, Pérez-Stable EJ, Stewart A, Barnes D, Kurland BF, et al. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology 2008;70:1163-1170.
68. Lanska DJ: Dementia mortality in the United States. Results of the 1986 National Mortality Followback Survey. Neurology 1998;50:362-367.
69. Akinyemi RO, Owolabi MO, Makanjuola VA, Ogunseyinde AO, Ogunniyi A: Frontotemporal dementia in a Nigerian woman: case report and brief review of the literature. Afr J Med Med Sci 2009;38:71-75.
70. Rohrer JD, Warren JD, Fox NC, Rossor MN: Presymptomatic studies in genetic frontotemporal dementia. Rev Neurol (Paris) 2013;169:820-824.